Legal status by country
Is MOTS-c with SS-31 legal?
Written by Aaron CuhaReviewed Sep 2026
How MOTS-c with SS-31 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | Elamipretide is investigational; MOTS-c is sold research use only and has no clinical development programme. The blend is supplied only by research chemical vendors. | Neither is licensed; supply for human use is unlawful. | None recorded | None recorded |
US FDA status: Neither is approved. Elamipretide has been through phase 3 development without an approval for this indication; MOTS-c has never entered clinical development.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.